Ani Pharmaceuticals (ANIP) Gross Margin Growth (5y) (2017 - 2026)

Ani Pharmaceuticals (ANIP) Gross Margin Growth (5y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn
10 Ani Pharmaceuticals 1.70 Bn 1.39 Bn 143.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 13,903.00
Dec 31, 2025 228.00
Sep 30, 2025 -302.00
Jun 30, 2025 740.00
Mar 31, 2025 675.00
Dec 31, 2024 -503.00
Sep 30, 2024 -1,330.00
Jun 30, 2024 -1,304.00
Mar 31, 2024 -793.00
Dec 31, 2023 -533.00
Sep 30, 2023 -571.00
Jun 30, 2023 -118.00
Mar 31, 2023 921.00
Dec 31, 2022 469.00
Sep 30, 2022 452.00
Jun 30, 2022 -60.00
Mar 31, 2022 -842.00
Dec 31, 2021 -1,138.00
Sep 30, 2021 -363.00
Jun 30, 2021 -825.00